Which European Defence Companies Are Most Exposed to SAFE Eligibility Constraints and Foreign-Control Screening Risk?
A legal-industrial assessment of ownership screening, design authority, and procurement autonomy under SAFE
The central issue is not foreign shareholding in the abstract, nor a simple distinction between European and non-European ownership. Under SAFE, the decisive question is how legal eligibility and industrial autonomy interact at the level of procurement, programme structure, and product architecture. A contractor may appear European at shareholder level yet still face material exposure if critical components originate outside the permitted perimeter, or if the company cannot legally or technically define, adapt, and evolve the product without non-European permissions, source-code access, export approvals, or design-control rights. The real analytical problem is therefore to identify the mechanisms through which ownership, control, technology origin, component thresholds, and modification rights can affect access to common procurement and programme participation.
The report is structured accordingly. It begins with the legal and institutional framework linking SAFE, EDIP, FDI screening, EDIRPA, and ASAP, and clarifies that these instruments overlap strategically but regulate different forms of risk. It then examines the meaning of non-associated third-country status, with dedicated treatment of Canada and the United Kingdom, before building a taxonomy of exposure profiles rather than a flat list of company names. The core chapters distinguish ownership and screening exposure from design-authority and product-evolution exposure, assess large European primes as programme-depth amplification cases, and conclude with a multi-axis framework separating exposure ranking from funding-access ranking, so that the most relevant risks can be assessed with greater legal and industrial precision.